How Is Zimmer Biomet Holdings’ Stock Performance Compared to Other Medical Devices Stocks?

Zimmer Biomet Holdings, Inc. (ZBH) is a leading global medical technology company that specializes in musculoskeletal healthcare solutions, including orthopedic reconstructive implants, sports medicine products, biologics, dental implants, and robotic-assisted surgical technologies used to treat disorders of bones, joints, and supporting soft tissues. Headquartered in Warsaw, Indiana, the company markets its products to hospitals, surgeons, and healthcare providers worldwide through direct sales and distributor networks. Zimmer Biomet currently has a market cap of roughly $18.7 billion.

Companies worth $10 billion or more are generally described as “large-cap stocks,” and Zimmer Biomet fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical devices industry. The firm traces its origins to 1927 and has grown into one of the major players in the orthopedic device industry.